The global ENT devices market is projected to reach $31.8 billion by 2030, advancing at a compound annual growth rate (CAGR) of 7.7% from its estimated value of $20.4 billion in 2024. This growth is primarily driven by the increasing prevalence of hearing disorders and sinusitis, coupled with a growing preference for minimally invasive procedures within the ENT specialty. Technological advancements have led to the development of sophisticated devices, enhancing diagnostic and therapeutic capabil